Cargando…
TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report
Epithelioid glioblastoma (EGBM, classified as glioblastoma, IDH wild type, grade 4 according to the fifth edition of the World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS) (WHO CNS5)) is a highly aggressive malignancy, with a median progression-free survival...
Autores principales: | Ding, Yuxuan, Wang, Qiang, Wang, Feijiang, Wu, Nan, Li, Jianrui, He, Xia, Pan, Hao, Wang, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136999/ https://www.ncbi.nlm.nih.gov/pubmed/37190598 http://dx.doi.org/10.3390/brainsci13040633 |
Ejemplares similares
-
First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis
por: Kassubek, Rebecca, et al.
Publicado: (2022) -
Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis
por: Li, Shupeng, et al.
Publicado: (2022) -
Epithelioid glioblastoma exhibits a heterogeneous molecular feature: A targeted next-generation sequencing study
por: Pan, Rui, et al.
Publicado: (2022) -
Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
por: Kessler, Almuth F., et al.
Publicado: (2018) -
The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
por: Oberheim-Bush, Nancy Ann, et al.
Publicado: (2022)